Delivery of vincristine sulfate-conjugated gold nanoparticles using liposomes: A light-responsive nanocarrier with enhanced antitumor efficiency

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 3081-3095

  Liu, Ying ^a   He, Man ^a   Niu, Mengmeng ^a   Zhao, Yiqing ^a   Zhu, Yuanzhang ^a   Li, Zhenhua ^b   Feng, Nianping ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Antitumor efficiency; Light triggered drug release; Liposomes; Vincristine sulfate; Vincristine sulfate gold nanoparticle conjugates

Indexed keywords

GOLD NANOPARTICLE; LIPOSOME; VINCRISTINE SULFATE; ANTINEOPLASTIC AGENT; DRUG CARRIER; GOLD; METAL NANOPARTICLE; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER TISSUE; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; FEMALE; FLOW CYTOMETRY; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; INTERNALIZATION; LIGHT EXPOSURE; MOUSE; NONHUMAN; NUDE MOUSE; QUANTITATIVE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; UTERINE CERVIX CANCER; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS;

MUS MUSCULUS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; DRUG CARRIERS; GOLD; HELA CELLS; HUMANS; LIPOSOMES; METAL NANOPARTICLES; MICE; MICE, NUDE; VINCRISTINE;

EID: 84928109893     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S79550     Document Type: Article

References (42)

1. Cai D, Gao W, He B, et al. Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy. Biomaterials. 2014;35:2283-2294.
2. Sampathkumar K, Arulkumar S, Ramalingam M. Advances in stimuli responsive nanobiomaterials for cancer therapy. J Biomed Nanotechnol. 2014;10:367-382.
3. Thambi T, Deepagan VG, Yoon HY, et al. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery. Biomaterials. 2014;35:1735-1743.
4. Mo R, Sun Q, Li N, Zhang C. Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids. Biomaterials. 2013;34:2773-2786.
5. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1:325-327.
6. Klassen NV, Kedrov VV, Ossipyan YA, et al. Nanoscintillators for microscopic diagnostics of biological and medical objects and medical therapy. IEEE Trans Nanobioscience. 2009;8:20-32.
7. Vigderman L, Zubarev ER. Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules. Adv Drug Deliv Rev. 2013;65:663-676.
8. Iyer AK, Khaled G, Fang J, Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today. 2006;11:812-818.
9. Song M, Wang X, Li J, Zhang R, Chen B, Fu D. Effect of surface chemistry modification of functional gold nanoparticles on the drug accumulation of cancer cells. J Biomed Mater Res A. 2008;86:942-946.
10. Jeong SY, Park SJ, Yoon SM, et al. Systemic delivery and preclinical evaluation of Au nanoparticle containing beta-lapachone for radiosensitization. J Control Release. 2009;139:239-245.
11. Polizzi MA, Stasko NA, Schoenfisch MH. Water-soluble nitric oxide-releasing gold nanoparticles. Langmuir. 2007;23:4938-4943.
12. Agasti SS, Chompoosor A, You CC, Ghosh P, Kim CK, Rotello VM. Photo regulated release of caged anticancer drugs from gold nanoparticles. J Am Chem Soc. 2009;131:5728-5729.
13. Mallidi S, Larson T, Aaron J, Sokolov K, Emelianov S. Molecular specific optoacoustic imaging with plasmonic nanoparticles. Opt Express. 2007;15:6583-6588.
14. Melancon MP, Lu W, Yang Z, et al. In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol Cancer Ther. 2008;7:1730-1739.
15. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol. 2004;49:N309-N315.
16. Lee J, Chatterjee DK, Lee MH, Krishnan S. Gold nanoparticles in breast cancer treatment: promise and potential pitfalls. Cancer Lett. 2014;347:46-53.
17. Mady MM, Fathy MM, Youssef T, Khalil WM. Biophysical characterization of gold nanoparticles-loaded liposomes. Phys Med. 2012;28:288-295.
18. Kim D, Park S, Lee JH, Jeong YY, Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc. 2008;129:7661-7665.
19. Kojima C, Hirano Y, Yuba E, Harada A, Kono K. Preparation and characterization of complexes of liposomes with gold nanoparticles. Colloids Surf B Biointerfaces. 2008;66:246-252.
20. Chithrani DB, Dunne M, Stewart J, Allen C, Jaffray DA. Cellular uptake and transport of gold nanoparticles incorporated in a liposomal carrier. Nanomedicine. 2010;6:161-169.
21. Paasonen L, Sipila T, Subrizi A, et al. Gold-embedded photosensitive liposomes for drug delivery: triggering mechanism and intracellular release. J Control Release. 2010;147:136-143.
22. Li D, Li G, Li P, et al. The enhancement of transfection efficiency of cationic liposomes by didodecyldimethylammonium bromide coated gold nanoparticles. Biomaterials. 2010;31:1850-1857.
23. Agarwal A, Mackey MA, El-Sayed MA, Bellamkonda RV. Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano. 2011;5:4919-4926.
24. Von White G 2nd, Chen Y, Roder-Hanna J, Bothun GD, Kitchens CL. Structural and thermal analysis of lipid vesicles encapsulating hydrophobic gold nanoparticles. ACS Nano. 2012;6:4678-4685.
25. Kassem LA, Gamal El-Din MM, Yassin NA. Mechanismms of vincristine-induced neurotoxicity: Possible reversal by erythropoietin. Drug Discov Ther. 2011;5:136-143.
26. Zhang P, Ling G, Sun J, et al. Multifunctional nanoassemblies for vincristine sulfate delivery to overcome multidrug resistance by escaping P-glycoprotein mediated efflux. Biomaterials. 2011;32:5524-5533.
27. Storhoff JJ, Elghanian R, Mucic RC, Mirkin CA, Letsinger RL. One-pot colorimetric differentiation of polynucleotides with single base imperfections using gold nanoparticle probes. J Am Chem Soc. 1998;120:1959-1964.
28. Zalba S, Navarro I, Troconiz IF, Tros de Iiarduya C, Garrido MJ. Application of different methods to formulate PEG-liposomes of oxaliplatin: evaluation in vitro and in vivo. Eur J Pharm Biopharm. 2012;81:273-280.
29. Lazarus GG, Revaprassdu N, Lopez-Viota J, Singh M. The electrokinetic characterization of gold nanoparicles, functionalized with cationic functional groups, and its' interaction with DNA. Colloids Surf B Biointerfaces. 2014;121:425-431.
30. Anuradha J, Abbasi Tasneem, Abbasi SA. An eco-friendly method of synthesizing gold nanoparticles using an otherwise worthless weed pistia (Pistiastratiotes L.). J Advanc Res. 2014; in press; doi: 10.1016/j.jare.2014.03.006.
31. Zhang X, Guo S, Fan R, et al. Dual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cells. Biomaterials. 2012;33:7103-7114.
32. Wang Y, Dou L, He H, Zhang Y, Shen Q. Multifunctional nanoparticles as nanocarrier for vincristine sulfate delivery to overcome tumor multidrug resistance. Mol Pharm. 2014;11:885-894.
33. Pan Y, Neuss S, Leifert A, et al. Size-dependent cytotoxicity of gold nanoparticles. Small. 2007;3:1941-1949.
34. Frens G. Controlled nucleation for regulation of particle-size in monodisperse gold suspension. Nat Phys Sci. 1973;241:20-22.
35. Pissuwan D, Niidome T, Cortie MB. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release. 2011;149:65-71.
36. Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148:135-146.
37. An X, Zhang F, Zhu Y, Shen W. Photo induced drug release from thermosensitive Gold nanoparticles-liposome using a Gold nanoparticles-switch. Chem Commun (Camb). 2010;46:7202-7204.
38. An X, Zhan F, Zhu Y. Smart photothermal-triggered bilayer phase transition in Gold nanoparticles-liposomes to release drug. Langmuir. 2013;29:1061-1068.
39. Xie S, Tao Y, Pan Y, et al. Biodegradable nanoparticles for intracellular delivery of antimicrobial agents. J Control Release. 2014;187:101-117.
40. Shahbazi MA, Almeida PV, Makila EM, et al. Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitter ionic bilayer ploymer surface engineering. Biomaterials. 2014;35:7488-7500.
41. He XM, Wolkers WF, Crowe JH, Swanlund DJ, Bischof JC. In situ thermal denaturation of proteins in dunning AT-1 prostate cancer cells: implication for hyperthermic cell injury. Ann Biomed Eng. 2004;32:1384-1398.
42. You J, Zhang R, Zhang G, et al. Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: a platform for near-infrared light-trigged drug release. J Control Release. 2012;158:319-328.